Cytori Therapeutics, (CYTX) Posts Q4 Loss of 12, Wider than Views
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.7 million.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Optimum Communications gets NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
